These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 28153995)

  • 21. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
    Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M;
    Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.
    Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation.
    Lip GY; Laroche C; Boriani G; Cimaglia P; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Popescu MI; Tica O; Hellum CF; Mortensen B; Tavazzi L; Maggioni AP
    Europace; 2015 Jan; 17(1):24-31. PubMed ID: 24957921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. More reasons why men and women are not the same (gender differences in electrophysiology and arrhythmias).
    Yarnoz MJ; Curtis AB
    Am J Cardiol; 2008 May; 101(9):1291-6. PubMed ID: 18435960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term efficacy of catheter ablation for paroxysmal atrial fibrillation in patients with Brugada syndrome and an implantable cardioverter-defibrillator to prevent inappropriate shock therapy.
    Kitamura T; Fukamizu S; Kawamura I; Hojo R; Aoyama Y; Komiyama K; Nishizaki M; Hiraoka M; Sakurada H
    Heart Rhythm; 2016 Jul; 13(7):1455-9. PubMed ID: 26961302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association Between Sex and Treatment Outcomes of Atrial Fibrillation Ablation Versus Drug Therapy: Results From the CABANA Trial.
    Russo AM; Zeitler EP; Giczewska A; Silverstein AP; Al-Khalidi HR; Cha YM; Monahan KH; Bahnson TD; Mark DB; Packer DL; Poole JE;
    Circulation; 2021 Feb; 143(7):661-672. PubMed ID: 33499668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atrial Rate-Responsive Pacing and Incidence of Sustained Atrial Arrhythmias in Patients with Implantable Cardioverter Defibrillators.
    Fontenla A; Salguero R; Martinez-Ferrer JB; Rodriguez A; Alzueta J; Garcia E; Basterra N; Romero R; Concha JF; Viñolas X; Villacastin J; Lopez-Gil M; Arribas F
    Pacing Clin Electrophysiol; 2016 Jun; 39(6):548-56. PubMed ID: 27001125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimating the incidence of atrial fibrillation in single-chamber implantable cardioverter defibrillator patients.
    Zweibel S; Cronin EM; Schloss EJ; Auricchio A; Kurita T; Sterns LD; Gerritse B; Lexcen DR; Cheng A
    Pacing Clin Electrophysiol; 2019 Feb; 42(2):132-138. PubMed ID: 30478983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The assessment of factors influencing occurrence of adequate interventions of cardiac resynchronization therapy with cardioverter-defibrillator implanted in primary prevention of sudden cardiac death in dilative cardiomyopathy and percentage of biventricular pacing].
    Lelakowski J; Rydlewska A; Lelakowska M; Pudło J; Piekarz J; Matusik P
    Przegl Lek; 2017; 74(4):157-62. PubMed ID: 29696953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks.
    van Boven N; Theuns D; Bogaard K; Ruiter J; Kimman G; Berman L; VAN DER Ploeg T; Kardys I; Umans V
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1116-22. PubMed ID: 23889733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender Differences in Clinical Outcomes after Catheter Ablation of Atrial Fibrillation.
    Kaiser DW; Fan J; Schmitt S; Than CT; Ullal AJ; Piccini JP; Heidenreich PA; Turakhia MP
    JACC Clin Electrophysiol; 2016 Nov; 2(6):703-710. PubMed ID: 29623299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
    Al-Khatib SM; Stevenson WG; Ackerman MJ; Bryant WJ; Callans DJ; Curtis AB; Deal BJ; Dickfeld T; Field ME; Fonarow GC; Gillis AM; Granger CB; Hammill SC; Hlatky MA; Joglar JA; Kay GN; Matlock DD; Myerburg RJ; Page RL
    J Am Coll Cardiol; 2018 Oct; 72(14):e91-e220. PubMed ID: 29097296
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gender differences in device therapy for malignant ventricular arrhythmias.
    Horton HL; Marinchak RA; Rials SJ; Kowey PR
    Arch Intern Med; 1995 Nov; 155(21):2342-5. PubMed ID: 7487260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical decisions in the management of sudden cardiac death and malignant ventricular arrhythmias. Subendocardial resection, the automatic internal defibrillator, or both.
    Hargrove WC; Josephson ME; Marchlinski FE; Miller JM
    J Thorac Cardiovasc Surg; 1989 Jun; 97(6):923-8. PubMed ID: 2724998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Camm CF; James CA; Tichnell C; Murray B; Bhonsale A; te Riele AS; Judge DP; Tandri H; Calkins H
    Heart Rhythm; 2013 Nov; 10(11):1661-8. PubMed ID: 23994726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant sustained ventricular tachyarrhythmias in women: characteristics and outcome of treatment with an implantable cardioverter defibrillator.
    Kudenchuk PJ; Bardy GH; Poole JE; Dolack GL; Gleva MJ; Reddy R; Jones GK; Troutman C; Anderson J; Johnson G
    J Cardiovasc Electrophysiol; 1997 Jan; 8(1):2-10. PubMed ID: 9116964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrio-ventricular junction ablation and pacemaker treatment: a comparison between men and women.
    Carnlöf C; Insulander P; Jensen-Urstad M; Iwarzon M; Gadler F
    Scand Cardiovasc J; 2018 Jun; 52(3):120-126. PubMed ID: 29537317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.